Tag Archive: oncology

Jan 24 2019

Cervical Health Awareness Month – Cervical Cancer: Prevention, Detection, Development

By Amy Lane, Scientist at Cato Research   As Cervical Health Awareness Month comes to a close, it is a good time to review the state of cervical cancer, what you can do personally, and what is happening in drug development. Cervical cancer is most often caused by the human papillomavirus (HPV) and generally develops …

Continue reading »

Dec 19 2012

FDA: The Year in Review (2012)

On 10 Dec 2012, the FDA released a report titled, “FY 2012 Innovative Drug Approvals,” which discusses the FDA’s 2012 novel drug approvals and the focus on the advancement of regulatory science in to improve the drug approval process. Thirty-five novel drugs were approved by the FDA in 2012, matching the number of approvals in …

Continue reading »

May 02 2012

Cato Research Canada Celebrates Two Decades of Success in the Drug Development Industry

Over the past 5 years, the life sciences industry throughout Canada, and especially in Québec, has been extensively challenged. Capitalizing on strong relationships built over years with clients and partners has helped Cato Research continue to provide excellent services and weather the industry’s roller coaster ride. On 03 May 2012, Cato Research Canada will celebrate its 20th anniversary with a celebratory wine tasting. You are invited to join us and other industry representatives to talk about the changing climate for pharmaceutical and biotechnology companies in Canada.

Sep 19 2011

FDA Reorganizes Oncology and Hematology Divisions

When we are no longer able to change a situation, we are challenged to change ourselves. Victor Frankl The FDA recently announced that it is reorganizing three divisions (Hematology Products, Drug Oncology Products, and Biologic Oncology Products) from the Office of Oncology Drug Products into a new office: The Office of Hematology and Oncology Products …

Continue reading »

Jul 14 2011

Recap of the DIA Annual Meeting 2011

The 47th Annual DIA Meeting was held on 19-23 June 2011 in Chicago and was a great success with thousands of attendees from the health care industry and regulators from around the world including representatives from the FDA, the EMA, and many other global agencies. This year’s keynote speaker was the renowned AIDS researcher and …

Continue reading »

May 12 2011

Conference Recap – Biomarker World Congress 2011

  Everywhere in the news today, we hear that we are in the era of personalized medicine – where new medicines will be tailor-made for individual patients.  Specifically, personalized medicine is dedicated to the concept hat the right drug is administered to the right patient at the right dose at the right time.  To get …

Continue reading »

Mar 25 2011

Recap of the NCCN 16th Annual Conference

The 16th Annual National Comprehensive Cancer Network Conference (NCCN): Clinical Practice Guidelines and Quality Cancer Care, was held on 09-13 March 2011 in Hollywood, FL.  The conference hosted almost 2,000 registrants including oncologists, nurses, pharmacist, and other health care professionals. The general sessions provided updates to the changes in the guidelines for various cancers along …

Continue reading »

Sep 23 2010

35th European Society for Medical Oncology Congress

Image via Wikipedia The annual European Society for Medical Oncology (ESMO) meeting brings together medical oncologists from both Europe and all parts of the world.  As per ESMO’s 2010 meeting President, Dr. David Kerr, announcement: The ESMO Congress is a magnetic meeting point for worldwide medical oncology specialists and the ideal forum to present and …

Continue reading »

Jun 30 2010

Cato at the 12th World Congress on Gastrointestinal Cancer

Cato Research will be attending the European Society for Medical Oncology‘s (ESMO)  12th World Congress on Gastrointestinal Cancer in Barcelona, Spain from 30 June to 03 July 2010.  ESMO is the leading European professional organization representing medical oncologists.  The conference will focus on personalized therapy, multidisciplinary management and unraveling molecular mechanisms related to malignancies affecting …

Continue reading »

May 25 2010

Optimizing Drug Development and Preclinical Considerations for Oncology Indications

The Montgomery County (Maryland) Department of Economic Development will be hosting its next lunch meeting on Thursday, 27 May 2010 at the Shady Grove Innovation Center.  The topic of the meeting will be, “Optimizing Drug Development and Preclinical Considerations for Oncology Indications,” and the featured speakers will be Tariq Allana, Ph.D., and Jack Snyder, M.D., …

Continue reading »

Older posts «